Effects of Delayed Rapamycin Treatment on Renal Fibrosis and Inflammation in Experimental Ischemia Reperfusion Injury

Transplantation Proceedings

Volumn 41, Issue 10, 2009, Pages 4065-4071

  Liu, M ^a   Agreda, P ^a   Crow, M ^a   Racusen, L ^a   Rabb, H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 4; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN; RANTES; RAPAMYCIN; TUMOR NECROSIS FACTOR ALPHA;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; C57BL 6 MOUSE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; HISTOPATHOLOGY; KIDNEY FIBROSIS; KIDNEY ISCHEMIA; LYMPHOCYTE ACTIVATION; MALE; MOUSE; NEPHRITIS; NONHUMAN; ORGAN SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REPERFUSION INJURY; SHAM PROCEDURE; T LYMPHOCYTE; THERAPY DELAY; TREATMENT DURATION; URINARY EXCRETION; WEIGHT GAIN; WOUND HEALING;

ALBUMINURIA; ANIMALS; BODY WEIGHT; CYTOKINES; FIBROSIS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, SUBCUTANEOUS; KIDNEY; KIDNEY DISEASES; MALE; MICE; MICE, INBRED C57BL; ORGAN SIZE; REPERFUSION INJURY; SIROLIMUS; WEIGHT GAIN;

EID: 71249111632     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.08.083     Document Type: Article

References (42)

1. Boletis J., Balitsari A., Filiopoulos V., et al. Delayed renal graft function: the influence of immunosuppression. Transplant Proc 37 (2005) 2054
2. Troppmann C., Gillingham K.J., Gruessner R.W., et al. Delayed graft function in the absence of rejection has no long-term impact. A study of cadaver kidney recipients with good graft function at 1 year after transplantation. Transplantation 61 (1996) 1331
3. Shoskes D.A., and Cecka J.M. Effect of delayed graft function on short- and long-term kidney graft survival. Clin Transpl (1997) 297
4. Daly P.J., Power R.E., Healy D.A., et al. Delayed graft function: a dilemma in renal transplantation. BJU Int 96 (2005) 498
5. Leggat Jr. J.E., Ojo A.O., Leichtman A.B., et al. Long-term renal allograft survival: prognostic implication of the timing of acute rejection episodes. Transplantation 63 (1997) 1268
6. Asderakis A., Dyer P., Augustine T., et al. Effect of cold ischemic time and HLA matching in kidneys coming from "young" and "old" donors: do not leave for tomorrow what you can do tonight. Transplantation 72 (2001) 674
7. Koning O.H., Ploeg R.J., van Bockel J.H., et al. Risk factors for delayed graft function in cadaveric kidney transplantation: a prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors. European Multicenter Study Group. Transplantation 63 (1997) 1620
8. Di P.S., Stallone G., Schena A., et al. Hypertension is an independent predictor of delayed graft function and worse renal function only in kidneys with chronic pathological lesions. Transplantation 73 (2002) 623
9. Lehtonen S.R., Isoniemi H.M., Salmela K.T., et al. Long-term graft outcome is not necessarily affected by delayed onset of graft function and early acute rejection. Transplantation 64 (1997) 103
10. Quiroga I., McShane P., Koo D.D., et al. Major effects of delayed graft function and cold ischaemia time on renal allograft survival. Nephrol Dial Transplant 21 (2006) 1689
11. McLaren A.J., Jassem W., Gray D.W., et al. Delayed graft function: risk factors and the relative effects of early function and acute rejection on long-term survival in cadaveric renal transplantation. Clin Transplant 13 (1999) 266
12. Sehgal S.N. Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clin Biochem 31 (1998) 335
13. Nankivell B.J., and Chapman J.R. Chronic allograft nephropathy: current concepts and future directions. Transplantation 81 (2006) 643
14. Inman S.R., Davis N.A., Olson K.M., et al. Rapamycin preserves renal function compared with cyclosporine A after ischemia/reperfusion injury. Urology 62 (2003) 750
15. Lieberthal W., Fuhro R., Andry C.C., et al. Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells. Am J Physiol Renal Physiol 281 (2001) F693
16. Lieberthal W., Fuhro R., Andry C., et al. Rapamycin delays but does not prevent recovery from acute renal failure: role of acquired tubular resistance. Transplantation 82 (2006) 17
17. Fuller T.F., Freise C.E., Serkova N., et al. Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury. Transplantation 76 (2003) 1594
18. Lui S.L., Chan K.W., Tsang R., et al. Effect of rapamycin on renal ischemia-reperfusion injury in mice. Transpl Int 19 (2006) 834
19. Boratynska M., Banasik M., Patrzalek D., et al. Sirolimus delays recovery from posttransplant renal failure in kidney graft recipients. Transplant Proc 37 (2005) 839
20. Yang B., Jain S., Pawluczyk I.Z., et al. Inflammation and caspase activation in long-term renal ischemia/reperfusion injury and immunosuppression in rats. Kidney Int 68 (2005) 2050
21. Burne-Taney M.J., Liu M., Ascon D., et al. Transfer of lymphocytes from mice with renal ischemia induce albuminuria in naive mice: a possible mechanism linking early injury to progressive renal disease?. Am J Physiol Renal Physiol 291 (2006) F19
22. Basile D.P., Donohoe D.L., Roethe K., et al. Chronic renal hypoxia after acute ischemic injury: effects of L-arginine on hypoxia and secondary damage. Am J Physiol Renal Physiol 284 (2003) F338
23. Chandraker A., Takada M., Nadeau K.C., et al. CD28-b7 blockade in organ dysfunction secondary to cold ischemia/reperfusion injury. Kidney Int 52 (1997) 1678
24. Myckatyn T.M., Ellis R.A., Grand A.G., et al. The effects of rapamycin in murine peripheral nerve isografts and allografts. Plast Reconstr Surg 109 (2002) 2405
25. Burne-Taney M.J., Yokota N., and Rabb H. Persistent renal and extrarenal immune changes after severe ischemic injury. Kidney Int 67 (2005) 1002
26. Molls R.R., Savransky V., Liu M., et al. Keratinocyte-derived chemokine is an early biomarker of ischemic acute kidney injury. Am J Physiol Renal Physiol 290 (2006) F1187
27. Rovira J., Marcelo A.E., Burke J.T., et al. Effect of mTOR inhibitor on body weight: from an experimental rat model to human transplant patients. Transpl Int 21 (2008) 992
28. Khamzina L., Veilleux A., Bergeron S., et al. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology 146 (2005) 1473
29. Yanchar N.L., Fedorak R.N., Kneteman N.M., et al. Nutritional and intestinal effects of the novel immunosuppressive agents: deoxyspergualin, rapamycin, and mycophenolate mofetil. Clin Biochem 29 (1996) 363
30. Dias V.C., Madsen K.L., Yatscoff R.W., et al. Orally administered immunosuppressants modify intestinal uptake of nutrients in rabbits. Transplantation 58 (1994) 1241
31. DiJoseph J.F., Sharma R.N., and Chang J.Y. The effect of rapamycin on kidney function in the Sprague-Dawley rat. Transplantation 53 (1992) 507
32. Yang B., Jain S., Pawluczyk I.Z., et al. Inflammation and caspase activation in long-term renal ischemia/reperfusion injury and immunosuppression in rats. Kidney Int 68 (2005) 2050
33. Bonegio R.G., Fuhro R., Wang Z., et al. Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy. J Am Soc Nephrol 16 (2005) 2063
34. Diekmann F., Rovira J., Carreras J., et al. Mammalian target of rapamycin inhibition halts the progression of proteinuria in a rat model of reduced renal mass. J Am Soc Nephrol 18 (2007) 2653
35. Hochegger K., Jansky G.L., Soleiman A., et al. Differential effects of rapamycin in anti-GBM glomerulonephritis. J Am Soc Nephrol 19 (2008) 1520
36. Bumbea V., Kamar N., Ribes D., et al. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus. Nephrol Dial Transplant 20 (2005) 2517
37. Sahin G.M., Sahin S., Kantarci G., et al. Proteinuria after conversion to sirolimus in renal transplant recipients. Transplant Proc 38 (2006) 3473
38. Franco A.F., Martini D., Abensur H., et al. Proteinuria in transplant patients associated with sirolimus. Transplant Proc 39 (2007) 449
39. Loverre A., Ditonno P., Crovace A., et al. Ischemia-reperfusion induces glomerular and tubular activation of proinflammatory and antiapoptotic pathways: differential modulation by rapamycin. J Am Soc Nephrol 15 (2004) 2675
40. Wu M.J., Wen M.C., Chiu Y.T., et al. Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis. Kidney Int 69 (2006) 2029
41. Viklicky O., Bohmova R., Ouyang N., et al. Effect of sirolimus on renal ischaemia/reperfusion injury in normotensive and hypertensive rats. Transpl Int 17 (2004) 432
42. Olivera D.L., Kaplan J.M., Newman-Tarr T., et al. Divergent effects of rapamycin on mouse and rat cells following mitogenic stimulation. Clin Immunol Immunopathol 68 (1993) 357